Description | Omaveloxolone (RTA-408) is a synthetic triterpenoid that activates the cytoprotective transcription factor Nrf2 and inhibits NF-κB signaling. Phase 2. |
---|
Targets | |
---|
In vitro | RTA 408 potently increases expression of Nrf2 target genes and reverses IFNγ-mediated suppression of Gclc expression in RAW 264.7 cells. In a panel of eight human tumor cell lines, RTA 408 inhibits growth with an average GI50 value of 260 nM and induces apoptosis. RTA 408 also inhibits NF-κB and activates JNK in tumor cells. [1] |
---|
In vivo | In mice with radiation-induced dermatitis, 1.0% RTA 408 markedly reduces epidermal and collagen thickening, prevents dermal necrosis and completely alleviates skin ulcers. [2] In rat skin, RTA 408 activates Nrf2 and induces cytoprotective genes. [3] RTA 408 also mitigates hematopoietic acute radiation syndrome in mice. [4] |
---|
Selleck Chemicals一直专注于生命科学领域高端试剂的开发与研究,旨在以最优价格为客户提供最优质的科研试剂服务。我们的产品包括抗体,重组蛋白,干扰rna,多肽,小分子激酶抑制剂等。Selleck Chemicals拥有一支热情与活力并存,经验与技术兼备的技术支持与客户服务团队,凭借在生命科学领域的多年研发经验,公司与多达2万多个客户建立了长期稳定的合作关系,其中包括世界各大制药厂,生物科技公司,医院及各大临床诊断实验室,世界各著名高校、研究所以及政府机关。